Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2011 1
2013 1
2017 1
2020 1
2021 2
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Your search for aethylmethylhydroxypyridini succinas retrieved no results
[Post-COVID-19 asthenic syndrome].
Zolotovskaia IA, Shatskaia PR, Davydkin IL, Shavlovskaya OA. Zolotovskaia IA, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(4):25-30. doi: 10.17116/jnevro202112104125. Zh Nevrol Psikhiatr Im S S Korsakova. 2021. PMID: 34037351 Clinical Trial. Russian.
Patients were randomized into two groups: in the main group (n=64), ethylmethylhydroxypyridine succinate (Neurox) was prescribed 1 tablet (125 mg) 3 times a day for 4 weeks; in the comparison group (n=65), medical drugs (MD) did not contain substances from the pharm …
Patients were randomized into two groups: in the main group (n=64), ethylmethylhydroxypyridine succinate (Neurox) was prescrib …
[he use ethylmethylhydroxypyridine succinate in the treatment of patients with heart failure].
Sidorenko GI, Komissarova SM, Zolotukhina SF, Petrovskaia ME. Sidorenko GI, et al. Kardiologiia. 2011;51(6):44-8. Kardiologiia. 2011. PMID: 21878070 Clinical Trial. Russian.
We studied impact of ethylmethylhydroxypyridine succinate n the course of chronic heart failure during 3 years follow-up after myocardial infarction. ...The latter changes were indicative of antioxidant, anti-inflammatory, anti-stress activities of Ethylmethylhyd
We studied impact of ethylmethylhydroxypyridine succinate n the course of chronic heart failure during 3 years follow-up after …
[New opportunities for neuroprotective therapy of patients in the acute and early recovery period of ischemic stroke].
Tanashyan MM, Raskurazhev AA, Zaslavskaya KI, Kuznetsova PI, Merkulova IY. Tanashyan MM, et al. Ter Arkh. 2022 Aug 4;94(6):748-755. doi: 10.26442/00403660.2022.06.201743. Ter Arkh. 2022. PMID: 36286852 Clinical Trial. Russian.
AIM: To evaluate the efficacy and safety of Brainmax in comparison with ethylmethylhydroxypyridine succinate and trimethylhydrazinium propionate in patients with ischemic stroke in the acute and early recovery period. ...Comparison of cognitive function indicators a …
AIM: To evaluate the efficacy and safety of Brainmax in comparison with ethylmethylhydroxypyridine succinate and trimethylhydr …
[Efficacy of Mexidol in patients with chronic brain ischemia and cognitive impairment of different age groups (results of sub-analysis of the international multicenter, randomized, double-blind, placebo-controlled study of sequential therapy in patients with chronic brain ischemia MEMO)].
Zakharov VV, Tkacheva ON, Mkhitaryan EA, Fedin AI. Zakharov VV, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(11. Vyp. 2):73-80. doi: 10.17116/jnevro202212211273. Zh Nevrol Psikhiatr Im S S Korsakova. 2022. PMID: 36412160 Clinical Trial. Russian.
[Results of a multicentre double-blind randomised placebo-controlled clinical trial evaluating the efficacy and safety of Mexidol in the treatment of Attention Deficit Hyperactivity Disorder in Children (MEGA)].
Zavadenko NN, Suvorinova NY, Batysheva TT, Bykova OV, Platonova AN, Gaynetdinova DD, Levitina EV, Mashin VV, Vakula IN, Maximova NE. Zavadenko NN, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(4):75-86. doi: 10.17116/jnevro202212204175. Zh Nevrol Psikhiatr Im S S Korsakova. 2022. PMID: 35485068 Clinical Trial. Russian.
[Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)].
Fedin AI, Zakharov VV, Tanashyan MM, Chukanova EI, Madzhidova EN, Shchepankevich LA, Ostroumova OD. Fedin AI, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(11):7-16. doi: 10.17116/jnevro20211211117. Zh Nevrol Psikhiatr Im S S Korsakova. 2021. PMID: 34932280 Clinical Trial. Russian.
[Efficacy and safety of mexidol across age groups in the acute and early recovery stages of hemispheric ischemic stroke (results of additional sub-analysis of a randomized double blind multicenter placebo-controlled study, in parallel groups trial EPICA)].
Stakhovskaya LV, Mkhitaryan EA, Tkacheva ON, Ostroumova TM, Ostroumova OD. Stakhovskaya LV, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(8. Vyp. 2):49-57. doi: 10.17116/jnevro202012008249. Zh Nevrol Psikhiatr Im S S Korsakova. 2020. PMID: 33016677 Clinical Trial. Russian.
[Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA)].
Stakhovskaya LV, Shamalov NA, Khasanova DR, Melnikova EV, Agafiina AS, Golikov KV, Bogdanov EI, Yakupova AA, Roshkovskaya LV, Lukinykh LV, Lokshtanova TM, Poverennova IE, Shepankevich LA. Stakhovskaya LV, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(3. Vyp. 2):55-65. doi: 10.17116/jnevro20171173255-65. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. PMID: 28665371 Clinical Trial. Russian.
13 results